Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:09 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | Third Rock Ventures II L.P. | 0 0% | -2,790,964 (Position Closed) | View |
| 2022-02-14 4:34 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | Point72 Asset Management L.P. | 0 0% | -4,000,000 (Position Closed) | View |
| 2022-01-28 1:42 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | Frazier Healthcare VI L.P. | 1,651,357 2% | -1,679,016 (-50.42%) | View |
| 2022-01-25 4:05 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | HIRSCHMAN ORIN | 0 0% | -4,000,000 (Position Closed) | View |
| 2021-02-16 5:06 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | Deer VII & Co. Ltd. | 0 0% | -2,263,365 (Position Closed) | View |
| 2021-02-08 10:15 am Purchase | 13G | Allena Pharmaceuticals Inc. ALNA | FMR LLC | 2,296,083 4.584% | 820,200 (+55.57%) | View |
| 2021-01-25 4:20 pm Purchase | 13G | Allena Pharmaceuticals Inc. ALNA | HIRSCHMAN ORIN | 4,000,000 8% | 4,000,000 (New Position) | View |
| 2021-01-13 09:02 am Sale | 13G | Allena Pharmaceuticals Inc. ALNA | Empery Asset Management LP | 0 0% | -2,792,683 (Position Closed) | View |
| 2021-01-06 1:01 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | SABBY MANAGEMENT LLC | 269,836 11% | -2,522,847 (-90.34%) | View |
| 2020-12-10 5:10 pm Purchase | 13G | Allena Pharmaceuticals Inc. ALNA | Point72 Asset Management L.P. | 4,000,000 8% | 4,000,000 (New Position) | View |
| 2020-06-09 11:23 am Purchase | 13G | Allena Pharmaceuticals Inc. ALNA | Empery Asset Management LP | 2,792,683 8.71% | 2,792,683 (New Position) | View |
| 2020-06-03 1:50 pm Purchase | 13G | Allena Pharmaceuticals Inc. ALNA | SABBY MANAGEMENT LLC | 2,792,683 11% | 2,792,683 (New Position) | View |
| 2020-05-07 4:11 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | MORGAN STANLEY MS | 191,938 0.8% | -1,061,909 (-84.69%) | View |
| 2020-03-30 4:11 pm Purchase | 13G | Allena Pharmaceuticals Inc. ALNA | MORGAN STANLEY MS | 1,253,847 5.1% | 835,771 (+199.91%) | View |
| 2020-02-14 4:05 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | PFM Health Sciences LP | 284,285 1.2% | -1,785,708 (-86.27%) | View |
| 2020-02-14 08:56 am Sale | 13G | Allena Pharmaceuticals Inc. ALNA | LYTTON LAURENCE W | 790,100 3.4% | -411,728 (-34.26%) | View |
| 2020-02-13 2:16 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | Altium Capital Management LP | 0 0% | -2,340,136 (Position Closed) | View |
| 2020-02-11 4:01 pm Sale | 13G | Allena Pharmaceuticals Inc. ALNA | HBM BioCapital II LP | 619,073 2.6% | -1,019,257 (-62.21%) | View |
| 2020-02-07 11:12 am Sale | 13G | Allena Pharmaceuticals Inc. ALNA | FMR LLC | 1,475,883 6.289% | -13,900 (-0.93%) | View |
| 2019-12-12 10:00 am Purchase | 13G | Allena Pharmaceuticals Inc. ALNA | LYTTON LAURENCE W | 1,201,828 5.1% | 1,201,828 (New Position) | View |